Prevention of sudden death
Identification and treatment of those at risk of sudden death is an
important part of the management of patients with HCM. The
known risk factors are family history of sudden death, recurrent
syncope, non-sustained ventricular tachycardia and abnormal BP
response during exercise. Patients with isolated risk factors need
to be monitored carefully. Those with more than two risk factors
clearly need treatment. Oral amiodarone and/or an implantable
cardiac defibrillator are the available options.
FFuurrtthheerr rreeaaddiinngg
Seggewiss H, Gleichmann U, Faber L. Percutaneous transluminal septal
myocardial ablation in hypertrophic obstructive cardiomyopathy: acute
results and 3-month follow-up in 25 patients. J Am Coll Cardiol1998; 3311 :
252–8.
Spirito P, Seidman CE, McKenna WJ et al.The management of hyper-
trophic cardiomyopathy. N Engl J Med1997 Mar 13; 333366 : 775–85.